Stock Information
Regeneron Pharmaceuticals Inc (REGN)
Ticker Symbol: REGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $84,424.30 mil
Piotroski score: 6
PE Ratio: 18.8455
EPS (TTM): 41.5481
Revenue (TTM): $133.17 M
Dividend Yield: 0.47980604%
ROE: 14.83%
Latest News
-
Regeneron Allergy Antibodies And Dupixent Data Reframe Growth Prospects
Fri, Feb 13, 2026 6:12 PM
-
Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/Y
Fri, Feb 13, 2026 3:23 PM
-
Where is Regeneron Pharmaceuticals (REGN) Headed According to Analysts?
Fri, Feb 13, 2026 2:57 PM
-
CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens
Fri, Feb 13, 2026 2:45 PM
-
Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors
Fri, Feb 13, 2026 9:23 AM
-
Baird Chautauqua International Growth Fund: Q4 2025 Winners, Laggards, Buys & Sells
Fri, Feb 13, 2026 5:45 AM
-
1 Healthcare Stock Worth Your Attention and 2 Facing Challenges
Fri, Feb 13, 2026 4:39 AM
-
Sanofi Tumbles After Board Shockingly Ousts CEO Paul Hudson
Thu, Feb 12, 2026 2:41 PM
-
Will Eylea Sales Decline Weigh on REGN's Top Line in 2026?
Thu, Feb 12, 2026 2:30 PM
-
Sanofi Shares Fall After CEO Change
Thu, Feb 12, 2026 12:36 PM
Key Financials
Financial data not available
